A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

For patients with human papillomavirus (HPV) type 16 (HPV16)-positive cervical intraepithelial neoplasia grade 3 (CIN3), vaccination with a replication-incompetent Semliki Forest virus vaccine ...

There was no clearance of other HPV types induced by Vvax001 ... “Our findings demonstrate that the therapeutic vaccine Vvax001 is safe, well-tolerated, and effective in eradicating HPV16 ...

A therapeutic vaccine targeting human papillomavirus type ... "Nearly all premalignant cervical lesions and cervical cancers are caused by HPV infection, with HPV16 implicated in the majority ...

A therapeutic vaccine targeting human papillomavirus type ... "Nearly all premalignant cervical lesions and cervical cancers are caused by HPV infection, with HPV16 implicated in the majority ...

HPV vaccines aim to prevent the development of HPV-related cancers by stopping the viral infection from taking hold in the ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

PHILADELPHIA – A therapeutic vaccine targeting human papillomavirus ... cervical lesions and cervical cancers are caused by HPV infection, with HPV16 implicated in the majority of cases ...